Malignant Soft Tissue Neoplasm — Trials

Malignant Soft Tissue Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,396 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 341
Recruiting: 190
Ph III recruiting: 14
Growth YoY: −18.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (200)

clinicaltrialsPublishedShowing 101–103 of 103 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06612671	Treatment Outcomes of Retroperitoneal Sarcoma	active not recruiting	—	150	Taichung Veterans General HospitalOTHER	1	Sep 25, 2024	clinicaltrials
NCT02565498	Preoperative vs Postoperative IMRT for Extremity/Truncal STS	active not recruiting	Phase 3	210	Mount Sinai Hospital, CanadaOTHER	3	Feb 20, 2024	clinicaltrials